Suppr超能文献

术前放疗在肾腺癌治疗中的应用

Preoperative irradiation in the treatment of renal adenocarcinoma.

作者信息

Juusela H, Malmio K, Alfthan O, Oravisto K J

出版信息

Scand J Urol Nephrol. 1977;11(3):277-81. doi: 10.3109/00365597709179965.

Abstract

The effect of preoperative irradiation on the survival of patients with renal adenocarcinoma was studied in a clinical trial. 88 patients with verified renal carcinoma entered the trial during 1968-1972, of whom 38, selected in a randomized fashion, received preoperative irradiation to a total dose of 3 300 rads in 3 weeks, followed by extrafascial nephrectomy after a 3 week interval; in the remainder an extrafascial nephrectomy was performed immediately. Actuarial 5-year survival was 47% in the "preoperative irradiation" group and 63% in the "nephrectomy-only" group, i.e. preoperative irradiation did not improve the 5-year prognosis. Survival was also studied in P-categories of the U.I.C.C. as well as in high and low grade malignancies. In none of these groups could we find a clear tendency to a more favourable prognosis with preoperative irradiation; no statistically significant differences were found. Because no improvement in prognosis after preoperative irradiation was found in our series or any of the sub-groups, we consider preoperative irradiation not routinely indicated as an adjuvant therapy. It may be useful in some selected cases, but selecting these cases will be difficult.

摘要

在一项临床试验中研究了术前放疗对肾腺癌患者生存率的影响。1968年至1972年期间,88例经证实的肾癌患者进入该试验,其中38例以随机方式入选,在3周内接受总量为3300拉德的术前放疗,间隔3周后行筋膜外肾切除术;其余患者立即行筋膜外肾切除术。“术前放疗”组的精算5年生存率为47%,“单纯肾切除术”组为63%,即术前放疗并未改善5年预后。还根据国际抗癌联盟(U.I.C.C.)的P分类以及高、低级别恶性肿瘤研究了生存率。在这些组中,我们均未发现术前放疗有明显的预后改善趋势;未发现有统计学意义的差异。由于在我们的系列研究或任何亚组中均未发现术前放疗后预后有所改善,因此我们认为术前放疗不作为辅助治疗的常规指征。它可能在某些特定病例中有用,但选择这些病例会很困难。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验